Your search returned 11 results.

Results
	1.	Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors: Herbolsheimer, Pia M Jelinek, James S Kapoor, R Perry, David J Smith, Karen L Swain, Sandra M Verma, Nitin Veytsman, Irina PMID: 22392508 Citation: Investigational New Drugs. 31(1):92-8, 2013 Feb. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Radiology Medline publication type: Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I DOI: http://dx.doi.org/10.1007/s10637-012-9805-y Add to cart (remove)
	2.	Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors: Swain, Sandra M PMID: 24129974 Year: 2013 Citation: Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM DOI: http://dx.doi.org/10.1007/s10549-013-2710-z Add to cart (remove)
	3.	Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA. MedStar authors: Swain, Sandra M PMID: 24869931 Year: 2014 Citation: Oncologist. 19(7):693-701, 2014 Jul. Institution: Washington Cancer Institute Form of publication: Journal Article All authors: Baselga J, Chan V, Clark E, Im SA, Im YH, Knott A, Miles D, Ross G, Swain SM DOI: http://dx.doi.org/10.1634/theoncologist.2014-0033 Add to cart (remove)
	4.	Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors: Kumar, Anjali S PMID: 26187751 Citation: Lancet Oncology. 16(8):957-66, 2015 Aug. Institution: MedStar Washington Hospital Center Department: Surgery/Colorectal Surgery Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG DOI: http://dx.doi.org/10.1016/S1470-2045(15)00004-2 Add to cart (remove)
	5.	Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma. MedStar authors: Barac, Ana PMID: 26439451 Year: 2016 Citation: Cancer. 122(1):124-30, 2016 Jan 1. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Atkins MB, Barac A, Freedman AN, Fu AZ, Jang S, Minasian L, Potosky AL, Tsai HT, Zheng C DOI: http://dx.doi.org/10.1002/cncr.29728 Add to cart (remove)
	6.	Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. MedStar authors: Sugarbaker, Paul H Yan, Tristan D PMID: 22614976 Year: 2012 Citation: Journal of Clinical Oncology. 30(20):2449-56, 2012 Jul 10. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Surgery/General Surgery Medline publication type: Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baratti D, Barrios P, Ceelen WP, Chua TC, de Hingh IH, Deraco M, Elias D, Gilly FN, Glehen O, Gomez Portilla A, Gonzalez-Moreno S, Levine EA, Liauw W, Moran BJ, Morris DL, Pelz JO, Piso P, Sardi A, Sugarbaker PH, Van Der Speeten K, Yan TD DOI: http://dx.doi.org/10.1200/JCO.2011.39.7166 Add to cart (remove)
	7.	Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors: Rao, Suman PMID: 30620668 Year: 2019 Citation: Journal of Clinical Oncology. 37(7):537-546, 2019 03 01. Institution: Medstar Franklin Square Medical Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J DOI: https://dx.doi.org/10.1200/JCO.18.00149 Add to cart (remove)
	8.	HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens. MedStar authors: Swain, Sandra M PMID: 27692565 Year: 2017 Citation: Clinical Breast Cancer. 17(1):76-78, 2017 Feb Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Gao JJ, Pohlmann PR, Swain SM, Tan M DOI: https://dx.doi.org/10.1016/j.clbc.2016.08.005 Add to cart (remove)
	9.	Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome. MedStar authors: Bijelic, Lana Ihemelandu, Chukwuemeka Sugarbaker, Paul H PMID: 25120250 Year: 2015 Citation: Annals of Surgical Oncology. 22(5):1680-5, 2015 May. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bijelic L, Ihemelandu C, Sugarbaker PH DOI: http://dx.doi.org/10.1245/s10434-014-3977-y Add to cart (remove)
	10.	Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. MedStar authors: Cruz, Allan-Louie PMID: 28453705 Year: 2017 Citation: Annals of Oncology. 28(5):1050-1056, 2017 May 01 Institution: MedStar Washington Hospital Center Department: Hematology/Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Barr PM, Brander DM, Cheson BD, Claxton DF, Cruz AL, Daniel C, Fanning M, Foon K, Gashonia L, Goy A, Henick Bachow S, Hill BT, Howlett C, Isaac K, Kennard KH, Kiselev P, Lamanna N, Lenhart J, Mato AR, Nabhan C, Pu JJ, Schuster SJ, Skarbnik AP, Svoboda J, Timlin C, Ujjani CS, Winter AM, Yacur M, Zent CS DOI: https://dx.doi.org/10.1093/annonc/mdx031 Add to cart (remove)
	11.	Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades. MedStar authors: Ihemelandu, Chukwuemeka Sugarbaker, Paul H PMID: 27878480 Year: 2017 Citation: Annals of Surgical Oncology. 24(4):898-905, 2017 Apr Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Surgery/General Surgery Medline publication type: Journal Article Form of publication: Journal Article All authors: Ihemelandu C, Sugarbaker PH DOI: https://dx.doi.org/10.1245/s10434-016-5698-x Add to cart (remove)

Powered by Koha